Royal Bank of Canada
SCMP

Royal Bank of Canada’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Royal Bank of Canada’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-246,000
Closed -$4.42M – 7216
2017
Q4 		$4.42M Buy
+246,000
New +$3.03M ﹤0.01% 2143

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Royal Bank of Canada's SCMP Position: Q1 2018 in Review

Royal Bank of Canada sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 8,619 shares — an estimated $154K sold.

Royal Bank of Canada first reported a position in SCMP in Q2 2013 and held it in 14 quarters. The position peaked at $1.08M in Q1 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Royal Bank of Canada reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Royal Bank of Canada sold 8,619 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $154K.
  • Royal Bank of Canada first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
  • Royal Bank of Canada's Sucampo Pharmaceuticals, Inc. position peaked at $1.08M in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Royal Bank of Canada's 13F filing for Q1 2018, filed 15 May 2018.